About: Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Změny ve fenotypu, periférní funkci krevních lymfocytů a také změny uvolněných, zánětlivých cytokinů doprovázejících podávání léku při první chemoterapii. Máme vyšetřený neopterin v moči a periférní krevní leukocyty fenotypu 44 karcinomů prsu léčených kombinací doxorubicinem a paclitaxelem. (cs) Changes in the phenotype, function of peripheral blood lymphocytes as well as alterations in the release of pro-inflammatory cytokines accompanying the administration of primary chemotherapy have been described. We have investigated urinary neopterin and peripheral blood leukocyte phenotype in 44 breast carcinoma patients treated with the combination of doxorubicin and paclitaxel. Changes in the phenotype, function of peripheral blood lymphocytes as well as alterations in the release of pro-inflammatory cytokines accompanying the administration of primary chemotherapy have been described. We have investigated urinary neopterin and peripheral blood leukocyte phenotype in 44 breast carcinoma patients treated with the combination of doxorubicin and paclitaxel. (en)
Title	Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma Aktivace imunitního systému a periférních krevních lymfocytů při první chemoterapii v kombinci s doxorubicinem a paclitaxelem (cs) Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma (en)
skos:prefLabel	Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma Aktivace imunitního systému a periférních krevních lymfocytů při první chemoterapii v kombinci s doxorubicinem a paclitaxelem (cs) Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma (en)
skos:notation	RIV/00216208:11150/07:00003555!RIV08-MZ0-11150___
http://linked.open.../vavai/riv/strany	25;34
http://linked.open...avai/riv/aktivita	P
http://linked.open...avai/riv/aktivity	P(NR8392)
http://linked.open...iv/cisloPeriodika	1
http://linked.open...vai/riv/dodaniDat	2008
http://linked.open...aciTvurceVysledku	Veselý, Pavel Vokurková, Doris Ryška, Aleš Melichar, Bohuslav Hornychová, Helena
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Univerzita Karlova v Praze / Lékařská fakulta v Hradci Králové
http://linked.open...dnocenehoVysledku	454066
http://linked.open...ai/riv/idVysledku	RIV/00216208:11150/07:00003555
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	breast carcinoma; lymphocytes; neopterin (en)
http://linked.open.../riv/klicoveSlovo	lymphocytes neopterin breast carcinoma
http://linked.open...odStatuVydavatele	DE - Spolková republika Německo
http://linked.open...ontrolniKodProRIV	[1231A0F9D7CF]
http://linked.open...i/riv/nazevZdroje	Pteridines
http://linked.open...in/vavai/riv/obor	FC
http://linked.open...ichTvurcuVysledku	5 (xsd:int)
http://linked.open...cetTvurcuVysledku	9 (xsd:int)
http://linked.open...vavai/riv/projekt	Predictive and prognostic factors in breast cancer patients treated with neoadjuvant chemotherapy
http://linked.open...UplatneniVysledku	2007
http://linked.open...v/svazekPeriodika	18
http://linked.open...iv/tvurceVysledku	Hornychová, Helena Melichar, Bohuslav Ryška, Aleš Veselý, Pavel Vokurková, Doris
issn	0933-4807
number of pages	10 (xsd:int)
http://localhost/t...ganizacniJednotka	11150
is http://linked.open...avai/riv/vysledek of	Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 47 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software